Details for New Drug Application (NDA): 021748
✉ Email this page to a colleague
The generic ingredient in GLUMETZA is metformin hydrochloride. There are forty-nine drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.
Summary for 021748
| Tradename: | GLUMETZA |
| Applicant: | Santarus Inc |
| Ingredient: | metformin hydrochloride |
| Patents: | 1 |
Suppliers and Packaging for NDA: 021748
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GLUMETZA | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021748 | NDA | Santarus, Inc. | 68012-002 | 68012-002-13 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68012-002-13) |
| GLUMETZA | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021748 | NDA | Santarus, Inc. | 68012-003 | 68012-003-16 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68012-003-16) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 500MG | ||||
| Approval Date: | Jun 3, 2005 | TE: | AB3 | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1GM | ||||
| Approval Date: | Jun 3, 2005 | TE: | AB3 | RLD: | Yes | ||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Mar 23, 2025 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Expired US Patents for NDA 021748
Complete Access Available with Subscription
